Risk of Cancer Following the Use of N-Nitrosodimethylamine (NDMA) Contaminated Ranitidine Products: A Nationwide Cohort Study in South Korea

Risk of Cancer Following the Use of N-Nitrosodimethylamine (NDMA) Contaminated Ranitidine Products: A Nationwide Cohort Study in South Korea

N-nitrosodimethylamine (NDMA), a known carcinogenic agent, was recently detected in some products of ranitidine. Several studies have investigated the detectability of NDMA, in drugs and their risks. However, only a few epidemiological studies have evaluated cancer risk from the use of such individu...

Full description

Bibliographic Details
Main Authors: Hong Jin Yoon, Jie-Hyun Kim, Gi Hyeon Seo, Hyojin Park
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Clinical Medicine
Subjects:
ranitidine
NDMA
cancer risk
claims data
famotidine
Online Access:https://www.mdpi.com/2077-0383/10/1/153

Similar Items

Similar Items